Myofibroblastic proliferation on mitral valve chordae tendineae: a distinctive lesion associated with alcoholic liver

L C Stout1, P J Boor, E B Whorton

  • 1Department of Pathology, University of Texas Medical Branch, Galveston 77550.

Human Pathology
|June 1, 1988
PubMed

Insights

Distinctive bulbous thickenings (BTs) on mitral valve chordae tendineae were found in 4.3% of adult hearts. These acquired lesions show a strong correlation with alcoholic liver disease, particularly in males.

Area of Science:

  • Cardiovascular Pathology
  • Gastroenterology
  • Histopathology

Background:

  • Mitral valve chordae tendineae are crucial for heart function.
  • Distinctive bulbous thickenings (BTs) are a rare finding in cardiac pathology.
  • The etiology and associations of BTs are not well understood.

Purpose of the Study:

  • To investigate the prevalence and histological characteristics of bulbous thickenings (BTs) on mitral valve chordae tendineae.
  • To determine any potential associations between BTs and specific patient conditions, particularly liver disease.

Main Methods:

  • Examination of 1,676 consecutive autopsies performed between 1980 and 1984.
  • Histological analysis using light and electron microscopy of identified BTs.
  • Statistical comparison of BT prevalence in patients with and without diagnosed liver disease.

Main Results:

  • Bulbous thickenings (BTs) were identified in 4.3% of 1,083 adult hearts, absent in pediatric cases.
  • Histology revealed BTs composed of myofibroblasts, collagen, and elastin, with no signs of inflammation.
  • A statistically significant correlation (P < 0.01) was found between BTs and alcoholic hepatitis or cirrhosis (29.8% vs. 7.7%).

Conclusions:

  • Bulbous thickenings (BTs) of the mitral valve chordae tendineae are acquired lesions.
  • BTs are strongly associated with alcoholic liver disease.
  • Further research may elucidate the specific mechanisms linking alcoholic liver disease and BT development.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...